Tagged: Vaccine

GSK’s Cervarix Vaccine…


http://www.dailystar.co.uk/news/latest-news/593546/hpv-cervical-cancer-vaccine-teenager-dancer-paralysed-jab

Teen dancer left paralysed after HPV cervical cancer vaccine

A TEENAGE dancer has been left paralysed from the waist down after taking the HPV vaccine which helps to prevent cervical cancer.

Chloe Brookes-Holder and her mother SWNS

TRAGIC: A teen dancer has been left paralysed after taking the HPV vaccine

Chloe Brookes-Holder was once a healthy 12-year-old who danced six days a week when given the jab.

But now, six years on, the 18-year-old remains stranded in hospital, emaciated and paralysed.

Chloe, of Cheltenham, Gloucestershire, said: “At first, my family and I didn’t put two and two together.

Chloe Brookes-Holder on a hospital bed SWNS

PARALYSED: Chloe Brookes-Holder remains stranded in hospital

“Since getting sick from something the NHS gave me I don’t trust any medical professionals that I don’t know”

Chloe Brookes-Holder

“We thought the vaccine was safe because they give it in schools and on the letter the parents were given to sign consent I remember reading ‘it saves lives’.”

She said in the months that followed getting the injection at school, she fell ill with dizziness, headaches, fatigue and bone and joint pain – which left her muscles weakened.

She has now lost three stones, dropping to just 5st and is now being fed through a tube.

For years, doctors told Chloe the condition was in her head but now some believe the injection triggered an autoimmute response, causing her body to attack itself.

The teen said: “We trust our government to keep us safe but now, since getting sick from something the NHS gave me I don’t trust any medical professionals that I don’t know.

“Why? Because I’ve been treated in such a barbaric way. It’s been ill on earth.”

Chloe Brookes-Holder in hospital SWNS

STRANDED: The 18-year-old is left paralysed from the waist down

Shocking photos show her hooked to wires and drips, as she lies in a hospital – where she has been for the past 11 months.

Her mother, Sophie Brookes, 41, has been forced to give her job up as a hairdresser to become her full-time carer.

The 18-year-old is certain her symptoms are linked to the vaccine, which protects against the human papilloma virus and cause cervical caner – this kills around 900 women a year.

Chloe Brookes-Holder in hospital SWNS

VACCINE: She has now lost three stones and is being fed through a tube

She said: “I danced six days a week and loved to go to after-school sport and dance clubs every night. I was on the right road to getting A’s at GCSE.

“I wanted to have a dance career and my heart bleeds with the torture knowing I may never walk again and therefore ever dance again.”

Parents have called for more research into the jab, which has been a routine offered to 12 and 13-year-old girls since 2008.

Chloe became ill between her second and third injection of the Cervarix vaccine in late 2010 and the summer of 2011.

She came down with a string of viruses, started experiencing debilitating muscle pain and was diagnosed with fibromyalgia.

A gastrointestinal disorder left her in agony every time she ate or lost control of her bladder.

Chloe Brookes-Holder before she became paralysed SWNS

ONCE A UPON A TIME: Chloe was once a healthy 12-year-old

She was later diagnosed with Postural Orthostatic Tachycardia Syndrome which causes abnormal heart rate.

A year after having the injection, Chloe also began experiencing paralytic episodes and collapsing at school, unable to control her lower body.

She said: “I’m not scaremongering, I just care about others. This is real. This is the pure ugly truth. I want to make people aware so they can make decisions for themselves.”

Chloe Brookes-Holder in hospital SWNS

SHOCKING: Photos show her hooked to wires and drips

Cervarix was given to 6 million girls and while it is no longer offered to girls at school by the NHS, a new HPV vaccine, Gardasil is.

European Medicines Agency statistics show that up to January 2017, 3,683 reactions to Cervarix were reported and 11,802 to Gardasil.

Some 380 families, represented by the UK Association for Vaccine Injured Daughters, have called for more information in schools and research into potential side effects.

Medics have dismissed their concerns and NHS England insists that the jab is not dangerous, writing on its website that it is a “safe vaccine”.

Freda Burrell, of the UK Association for Vaccine Injured Daughters, said: “Many medical professionals will not link the vaccine to the girls’ health problems.

“Yet common sense should speak loudly if their medical records were excellent prior to the vaccine and their health changed dramatically after they had the jab.”

Chloe Brookes-Holder with her mother Sophie SWNS

LOVE: Her mum has been forced to give up her job to become her full-time carer

Public Health England and the Medicines and Healthcare products Regulatory Agency issued a joint statement in response to the claims.

They said: “As with all vaccines, the safety of the HPV vaccine is under constant review. Every report of a suspected side effect is taken seriously.”

“That there is no credible evidence of a link between the HPV vaccine and a range of chronic illnesses.”

They concluded: “The European Medicines Agency has also rued out a link to Postural Orthostatic Tachycardia Syndrome.”

2 Comments
2 Comments

11 days ago
SteveHinks
In 2008 the UK Government, assuming that the HPV vaccine to be capable of preventing cervical cancer (without any evidence to support it can prevent a single case of cancer), did an Impact Assessment using £1.7 billion as the cost of using HPV vaccine for the next 100 years. They also failed to consider any cost of adverse reactions! even though there were huge numbers during the clinical trials.

11 days ago
SteveHinks

There is ZERO evidence that Cervarix and Gardasil will ever prevent a single case of cancer. The manufacturers, GSK and Merck, only ever state they are ‘intended to’ or ‘expected to’ but it will be 20 years before we find out.

Cervarix is expected to prevent 2 strains of HPV, Gardasil 4 strains and Gardasil9 9 strains but there are over 170 strains of HPV with at least 40 involved in cancers but scientists expect other strains, potentially more lethal, to take the place of those which might be prevented by the vaccines.

The World Health Organisation has a database of adverse drug reports at vigiaccess.org. There are over 72,000 reports of adverse events with this vaccine, including 280 deaths, WHO also acknowledges only 10% get reported.

What is worse there have been several reports of VACCINATED girls as young as 18 developing cervical cancer.

Thank you Chloe for being so brave and helping to out the truth about this awful vaccine which is costing taxpayers hundreds of millions of pounds and filling our hospitals with severely disabled patients.

If you suspect your daughter, or son, have developed serious autoimmune diseases following vaccination please contact the UK Association of HPV Vaccine Injured Daughters (AHVID) for help


http://www.japantimes.co.jp/news/2017/02/13/national/crime-legal/suit-opens-tokyo-court-cervical-cancer-vaccine-side-effects/

/

Suit opens in Tokyo court over cervical cancer vaccine side effects

by

Staff Writer

Twenty-eight girls and women suffering what they say are side effects from cervical cancer vaccines that were recommended by the government demanded compensation from the state and drugmakers Monday as their trial opened at the Tokyo District Court.

The plaintiffs, ranging in age from 15 to 22, said they have experienced a wide range of health problems, including pain all over their bodies and impaired mobility, after receiving the human papillomavirus (HPV) vaccines between 2010 and 2013.

Each is demanding ¥15 million in damages.

Erina Sonoda, a 20-year-old college student, said she started to suffer strong menstrual pain after receiving the second of three recommended shots of the Cervarix vaccine, and the pain spread to other parts of her body after the third vaccination.

Due to agonizing pain, Sonoda said she has difficulty walking without a cane and often must use a wheelchair.

“I felt acute pain as if someone was squashing my internal organs. … Such conditions have only gotten worse,” Sonoda told the court while sitting in a wheelchair.

“I received the shots because the government recommended it,” she said. “I want the government to take seriously its responsibility for causing us (to suffer from) such symptoms.”

Since last July, a total of 119 plaintiffs have filed similar suits with courts in Tokyo, Nagoya, Osaka and Fukuoka, according to Masumi Minaguchi, a lawyer representing the women.

The government and the drugmakers — GlaxoSmithKline PLC and Merck Sharp & Dohme Corp., who make the HPV vaccines Cervarix and Gardasil, respectively — sought Monday to dismiss the compensation claims.

Representatives of the drugmakers said the safety and effectiveness of the medicines against cervical cancer have been scientifically confirmed and denied there is any link between the alleged side effects and the vaccines.

The Health, Labor and Welfare Ministry began recommending in April 2013 that girls between 12 and 16 be vaccinated for cervical cancer. But the ministry halted the recommendation two months later following reports of side effects.

According to the ministry, 2,945 people out of the 3.39 million women who had received the shots by the end of last April have reported side effects.

A causal link between the HPV vaccines and reported symptoms remains unclear, and no scientific proof has been submitted.

A nationwide survey conducted by a health ministry research team between July and December 2015 found symptoms claimed as side effects of cervical cancer vaccines in both vaccinated and unvaccinated populations.

The team is conducting further detailed analysis of the data.

Cervical cancer is the second most common cause of cancer deaths in women under 40. Each year about 10,000 women develop the disease in Japan and around 2,900 die annually, according to the National Cancer Center.

The primary cause of cervical cancer is human papillomavirus, a common infection transmitted through sexual intercourse. The cervical cancer vaccines are believed to help prevent HPV.

In December 2015, the World Health Organization issued a statement criticizing the government’s decision to cease recommending the vaccine, saying that “policy decisions based on weak evidence, leading to lack of use of safe and effective vaccines, can result in real harm.”

Glaxo And Contaminated Vaccines… Fluarix…


https://www.lewrockwell.com/2017/02/dr-david-brownstein/contaminated-vaccines/

“…Other vaccines were found to be contaminated with stainless steel, iron, chromium, and the heavy metal nickel.  GlaxoSmithKline’s Fluarix vaccine for children was found to contain 11 different metals.

Once these foreign substances are injected into the body, they can stay around the injection site and can cause swelling and granulomas.  However, they can also be carried by the blood to distant areas of the body as well.  Since these particles cannot be degraded, they can induce a chronic inflammatory state such as an arthritic or autoimmune disorder.  Furthermore, the scientists state, “It is only the obvious that similar quantities of these foreign bodies can have a more serious impact on very small organisms like those of children.”

The authors further state the contamination found in the vaccines was “…similar to those found in…cases of environmental contamination caused by different pollution sources.  In most circumstances, the combinations of {foreign bodies} is very odd…and look like the result of the random formation occurring, for example, when waste is burnt.  In any case, whatever their origin, they should not be present in any injectable medicament, let alone in vaccines, more in particular those meant for infants.”…”


http://info.cmsri.org/the-driven-researcher-blog/dirty-vaccines-new-study-reveals-prevalence-of-contaminants

GSK’s Fluarix vaccine for children three years and older contained 11 metals and aggregates of metals. Similar aggregates to those identified in the vaccines have been shown to be prevalent in cases of leukemia, the researchers noted.

Many of the vaccines contained iron and iron alloys which, according to the researchers, “can corrode and the corrosion products exert a toxicity affecting the tissues”.

Glaxo’s Pandemrix Vaccine Causes Narcolepsy And Cataplexy In 7 year Old..


https://inews.co.uk/essentials/news/health/swine-flu-vaccine-pandemrix-test-case-high-court/

Parents of disabled children still fighting for compensation over swine flu vaccine

The DWP could be left with a £12m bill if it fails for a third time to overturn a ruling ordering it to pay £120,000 compensation to a 7-year-old who suffers from narcolepsy caused by the Swine Flu vaccine Pandemrix

The DWP could be left with a £12m bill if it fails for a third time to overturn a ruling ordering it to pay £120,000 compensation to a 7-year-old who suffers from narcolepsy caused by the Swine Flu vaccine Pandemrix. (Photo by Jeff J Mitchell/Getty Images)

On 10 December 2009, seven-year-old John was given a vaccination called Pandemrix against the pandemic influenza A (H1N1), commonly known as Swine Flu. Four months later, following extensive hospital examination he was diagnosed with narcolepsy and cataplexy, neurological conditions that will affect him for the rest of his life.

Narcolepsy is a very rare and incurable autoimmune sleep disorder caused by the destruction of the part of the brain that produces hypocretin, a peptide that regulates sleep. Sufferers regularly experience episodes of drowsiness or excessive daytime sleepiness. Cataplexy is a condition characterised by sudden, profound muscle paralysis, the onset of which takes several seconds, and often results in the sufferer collapsing.

These conditions may also be associated with hallucinations, behavioural and mood disturbance, as well as nightmares. John, now 14, experiences all of these symptoms.

Although millions of people in the UK received Pandemrix without complications, the 2009-10 pandemic vaccine has been found to have caused an epidemic of narcolepsy in the UK and in other European countries in which it was used. About 1,500 people across Europe are thought to be affected, of which about 100 have so far been identified in the UK. John, not his real name, is one of them.

Test case

Last month, the High Court heard an appeal from the Department for Work and Pensions (DWP) against a test case decision forcing it to pay £120,000 vaccine injury compensation to John.

In January 2012 he applied to the DWP for compensation under the Vaccine Damages Payments Act 1979. The claim was initially refused on grounds of lack of a causal connection between the vaccine and John’s development of narcolepsy and cataplexy.

“What I expect of a decent, caring society is that when vaccination programmes are implemented, they come with an implicit agreement between state and citizen that ‘should’ anything go wrong, that citizen will be looked after by the rest of us.”

Matt O’Neill, Chair, Narcolepsy UK

A few months later, a medical advisor to the government’s Vaccine Damages Unit said that there was, in fact, likely to be a causal connection, but that John’s condition had improved and his level of disablement was less than 60 per cent – the threshold required to meet “severe” disability criteria for awarding compensation. He was denied payment.

On 11 February 2014, then Secretary of State for Work and Pensions Iain Duncan Smith reversed his refusal decision of two years earlier, accepting that the vaccine had caused John’s narcolepsy and cataplexy. However, Mr Duncan Smith refused to accept that John was severely disabled, and his application for payment was therefore refused.

After John appealed the decision to the First Tier Tribunal, the DWP was ordered in September 2014 to pay out as it found his narcolepsy to be severe. The DWP refused and appealed to the Upper Tribunal, arguing that only problems John had now could be taken into account and not the future impact of his condition.

In June 2015, the Upper Tribunal rejected the DWP’s submissions and dismissed their appeal. The DWP agreed to and paid-out the £120,000 compensation to John. However, it decided to go to the Court of Appeal, maintaining that the proper approach to assessment of disability is to ignore any aspects of the disability that may be experienced in the future.

It is the first time the Court of Appeal is considering a case of vaccine injury compensation under the UK statutory compensation scheme. Its decision will be binding on all future assessments of disability brought under the 1979 Act. Payments were then fixed at £10,000. Now they are £120,000 per person, so with around 100 victims seeking compensation under the Act, the DWP will be faced with a £12m bill if it loses.

Defining an individual as ’60 per cent disabled’

At Thursday’s hearing Sir Terence Etherton who, as Master of the Rolls, is the second most senior judge in England and Wales, Lord Justice Davis and Lord Justice Underhill listened to the government’s case.  Adam Heppinstall, representing the Secretary of State, said the principal argument is that it was “wrong in law” for the Upper Tribunal to conclude that assessment of an individual’s disability under the statutory scheme require’s a decision maker to take into account that person’s likely future disablement in addition to his condition at the time of assessment.

“In this respect, the Upper Tribunal adopted a speculative approach, not called for by the legislation, which carries with it substantial problems and the risk of unfairness,” Mr Heppinstall said. “The Secretary of State calls for a more factual approach, in which only the present disablement can be taken into account.”

He told the court other grounds for appeal centred on how someone is assessed as “severely disabled” and that the case raises “fundamental issues” which go to the heart of how all claims under the 1979 Act should be assessed and decided by the Secretary of State.

George Peretz QC, representing John, told the court: “There is nothing ‘speculative’ about looking at the impact of that continuing disability on an 11 year old boy as he progresses into manhood, taking into account the additional opportunities and responsibilities which that transition in life brings with it.

“The Upper Tribunal adopted a speculative approach, not called for by the legislation, which carries with it substantial problems and the risk of unfairness. The Secretary of State calls for a more factual approach, in which only the present disablement can be taken into account.”

Adam Heppinstall, counsel, Secretary of State for Work and Pensions

“As the Upper Tribunal rightly pointed out, the fact that injuries such as loss of a hand are regarded as amounting to 100 per cent disablement, and that, amputation of one leg at the knee is to be regarded as 60 per cent disablement, may be useful in providing a broad framework or starting point in assessing whether John’s narcolepsy with cataplexy amounts to 60 per cent disablement.

“Such a check, for example, rules out any suggestion that 100 per cent disablement is akin to total quadriplegia or a persistent vegetative state or that 60 per cent disablement cannot be established where an individual is able to carry on a reasonable range of daily activities.”

Mr Peretz used the example of paralympian and double-amputee Oscar Pistorious, who is defined as “100 per cent disabled”, yet was still able to compete at the Olympic Games.

Sir Terence said that it was obviously an important matter – not just for John and his family, but for the 30 outstanding cases waiting on the result. The judges reserved their decision.

Pandemrix: Another GSK Drug Scandal “As Big As Thalidomide”?


https://inews.co.uk/essentials/news/health/swine-flu-vaccine-pandremix-narcolepsy-victims-campaign-inquiry/

‘The swine flu vaccine triggered my daughter’s narcolepsy – now I want justice’

Clara Crisp with her daughter Mathilda, who began suffering extreme night-time sleep disturbance within two weeks of the vaccine and subsequently developed cataplexy

Clara Crisp with her daughter Mathilda, who began suffering extreme night-time sleep disturbance within two weeks of the vaccine and subsequently developed cataplexy

Campaigners are calling for a Europe-wide public inquiry into how a vaccine triggered devastating health sleep and brain disorders in a scandal they claim is as big as thalidomide.

Almost 1,700 people suffered narcolepsy after being vaccinated for swine flu. They are vowing to continue their fight for justice at the European Union.

The group of Europeans, including nearly 100 Britons, are calling for a public inquiry after suffering the debilitating disease which was triggered by use of the Pandemrix vaccine to treat the 2009/10 swine flu outbreak.

Narcolepsy is a rare neurological condition that affects the brain’s ability to regulate the normal sleep-wake cycle. This can lead to symptoms such as disturbed night-time sleep, excessive daytime sleepiness and cataplexy – the term given to sudden muscular weakness triggered by strong emotions such as laughter, anger and surprise. As a result, narcolepsy is often thought of as a sleep disorder, but its underlying cause means that it is better classified as a disorder of the central nervous system.

Families denied compensation

British families have been denied compensation from the Department of Work and Pensions under its compensation scheme as the Government does not recognise the condition as a “severe disability”.

Representatives of national narcolepsy groups from the UK, Ireland, Sweden, Finland, Denmark and Norway, and parents of affected children, met Vytenis Andriukaiti, EU commissioner for health and food safety, in Brussels in December.

They pressed him for recognition of the incident, and a public inquiry into lessons learnt for future pandemics. The group also called for the introduction of vaccine injury compensation standards across the EU, as there is a wide disparity in statutory vaccine injury compensation methods. They also called for clarity surrounding funding for research into treatment.

Unclear how vaccine triggered condition

While the vast majority of Pandemrix recipients had no adverse effects, there are now 1,698 adults and children across Europe registered in the EU database of adverse drug reactions who have developed narcolepsy following use of the H1N1 vaccine. While GlaxoSmithKline (GSK), the maker of Pandemrix, has acknowledged the link, and some patients and their families have been awarded compensation, how the vaccine triggered the condition is unclear.

Peter Todd, a solicitor who represents 88 injured people, compared the situation to the thalidomide scandal of the late 1950s and early 1960s. “Everybody is aware of thalidomide, but I think Pandemrix/narcolepsy is a bigger incident because the EU’s database has 1,698 people registered – and that’s a passive surveillance system,” he told i.

Similar to Thalidomide

“While there were hundreds of cases of birth defects caused by thalidomide, most cases involved shortening of one limb. I know that there were a few cases of multiple limbs shortening, but most cases were one and overall, if you weigh it up, it’s broadly comparable. Yet it doesn’t have the same public recognition.

“It’s now about seven years on from the pandemic and it did take considerable time for the epidemiology of Pandemrix and narcolepsy to become clear – the UK’s study in relation to adults and Pandemrix/narcolepsy was only published earlier this year. While the science is now settled you can’t find any clear acceptance of the incident on any EU or national government website. You can’t point to anything that amounts to official recognition. That’s why recognition from the EU is so important.”

‘Round-the-clock care for my daughter’

img_2684
Mathilda, now 10, needed extreme measures to improve her condition

Narcolepsy is incurable and sufferers have a lifetime of managing the symptoms. Claire Crisp’s daughter Mathilda is one of the children affected following her swine flu vaccination. She began suffering extreme night-time sleep disturbance within two weeks of the vaccine and subsequently developed cataplexy. Within two months Mathilda, now 10, needed round-the-clock care.

“Mathilda was eventually diagnosed with narcolepsy with cataplexy,” Ms Crisp, 46, told i from the family home in California, where they felt compelled to go to seek help. “What followed was a year of battling for effective treatment whilst Mathilda continued to deteriorate.

“My husband looked for a job in California, which was not in our life plan, but we were desperate as carers, as a family, and convinced that if Mathilda didn’t get the treatment she needed, she would lose her childhood.

“Mathilda’s case was extreme, and extreme measure were needed to rescue her. I did everything I could to give her her life back. It was huge risk as we sold our home [to pay for treatment] and left our families and lives back in the UK. But I could never have lived with myself if I didn’t fight for her.”

Ms Crisp has written a book on her family’s trauma called Waking Mathilda – A Memoir of Childhood Narcolepsy, to be released this spring.

Mr Todd said: “We don’t want to undermine the vaccine or do down [its maker] GSK, but … for those that have been affected, it is quite important to have some kind of official recognition of what happened.”

Are GSK Responsible For This Woman’s Death?…


http://www.mirror.co.uk/news/uk-news/nursery-nurse-killed-herself-after-8610711

Nursery nurse ‘killed herself after developing sleep disorder after she received swine flu vaccine’

Katie Clack, 23, became depressed after developing narcolepsy in 2009 and jumped to her death from a car park five years later

PA Katie Clack as a coroner has concluded it is "most likely" that the nursery nurse developed the sleep disorder narcolepsy as a result of receiving a swine flu vaccination
Katie Clack fell from a car park after developing the sleep disorder narcolepsy

A nursery nurse killed herself after becoming depressed over a sleep disorder which “most likely” developed after she received a swine flu vaccination, an inquest heard.

Katie Clack, 23, became depressed after developing narcolepsy in 2009.

She jumped to her death from the top of a multi-storey car park in Peterborough in September 2014.

Her narcolepsy had led to her sleeping for up to 19 hours per day on occasions and her mental health worsened.

An inquest in Stamford heard that the Peterborough woman did not want the vaccine but was required to take it for her job.

Recording a narrative conclusion, Paul Cooper, acting senior coroner for South Lincolnshire, said studies showed there were “significantly raised odds of narcolepsy after (being given the) Pandemrix” vaccine in those aged 18 and above.

Hoax caller warned if she swears at anyone she could face a jail sentence

“On the available evidence on the association between vaccination with Pandemrix and onset of narcolepsy it seems most likely that receipt of this vaccine in December 2009 caused Miss Clack’s narcolepsy,” said Mr Cooper.

He added that narcolepsy triggers depression, though he noted the case of Ms Clack was “complex and very rare”.

A statement issued on behalf of Ms Clack’s family said: “Katie was an energetic young woman who had just discovered her passion working with children.

“Narcolepsy turned her life into a terrible daily struggle and drastically reduced her quality of life.

“We cannot believe she would have decided to take her own life had the balance of her mind not been disturbed.”

Ms Colvin added: “The Clack family has waited a long time for this inquest.

“It is important that the coroner has recognised the casual link between the vaccine and narcolepsy and the devastating impact this had on Katie’s short life.”

Earlier this year a boy who developed the sleeping disorder caused by the swine flu vaccine was awarded £120,000 in damages.

Josh Hadfield, 10, from Frome in Somerset, developed narcolepsy after receiving the Pandemrix vaccine six years ago.

In 2013, lawyers launched a class action on behalf of 38 Britons – including 19 children – who developed narcolepsy after having the vaccine.

Scientists from the former Health Protection Agency (HPA) said there was evidence of a link between the Pandemrix jab – manufactured by GlaxoSmithKline(GSK) – and narcolepsy in children.

HPA figures suggested one in 55,000 children vaccinated – about 20 in the UK – are thought to have developed narcolepsy.

Josh was awarded the money after an appeal against the Government, which had initially refused to pay as he was not “severely disabled” enough.

Speaking at the time, a spokesman for GlaxoSmithKline said: “We remain committed to carrying out additional research into the potential role of Pandemrix in the development of narcolepsy.”

It was also supporting investigations into reported cases.

Across Europe, about 31 million people are thought to have received the Pandemrix jab.

Narcolepsy is a rare but serious neurological disorder that affects about 31,000 people in Britain.

The condition can cause massive disruption to sleep and daily life.

A Department of Health spokesman said: “Katie’s death was tragic and we offer our sympathies to her family.

“Pandemrix vaccine was used to prevent serious illness and deaths during the swine flu pandemic in 2009/10.

“At the time, the possible association with narcolepsy was not known.”

Japanese Women Seek Justice For Damage From GSK’s Cervarix (Cervical Cancer Vaccine).


http://www.asahi.com/ajw/articles/AJ201607280028.html

945-million-yen lawsuit filed over cervical cancer vaccines

THE ASAHI SHIMBUN

July 28, 2016 at 14:00 JST

Photo/IllutrationPlaintiffs and their supporters head to Tokyo District Court on July 27 to submit a mass lawsuit related to side effects from cervical cancer vaccines. (Naoko Kawamura)

Sixty-three young women are seeking a combined 945 million yen ($9 million) in compensation in the first mass lawsuit concerning side effects from cervical cancer vaccines.

The women are suing the central government and pharmaceutical companies GlaxoSmithKline Plc and MSD KK.

The lawsuits were filed July 27 in the district courts at Tokyo, Osaka, Nagoya and Fukuoka. The plaintiffs are aged between 15 and 22.

The women argue they have suffered health problems, such as pain in various parts of their bodies, difficulty in walking and also impaired eyesight, as a result of taking the vaccines that were meant to prevent cervical cancer.

They were mostly in junior or senior high school when they took the vaccines between July 2010 and July 2013.

The vaccines under question are GSK’s Cervarix, which was approved for domestic use in 2009, and MSD’s Gardasil, which was approved in 2011.

The plaintiffs argue that reports had been filed overseas where the two vaccines were in use before Japan about various side effects, including cases of death and serious illness.

The women claim the central government bears responsibility for approving the vaccines and recommending their use without adequately looking into safety concerns despite knowing about the possible dangers.

The lawsuit argues that a legal causal relationship exists because common symptoms appeared among the plaintiffs after taking the vaccines.

According to officials at the health ministry, about 3.4 million women have taken the vaccines. As of the end of April, some 2,900 reports had been submitted by medical facilities and the pharmaceutical companies that indicated possible side effects. Of those cases, 1,600 were considered serious.

“We would like to refrain from commenting,” said a health ministry official with regard to the lawsuit. “We believe it is important to provide support while being there for those who are suffering.”

A GSK spokesperson declined comment on the grounds the company had not yet received a copy of the lawsuit.

MSD released a statement that said the company plans to submit evidence in court.

(This article was written by Seiko Sadakuni and Tomoyo Fukumiya.)

GSK And The “Toxic Batch”… Glaxo’s Unethical Shenanigans Stretch Back Decades…


http://www.vaccineinjury.ie/vaccine-support-history.html

Irish Vaccine Injury Support Group

History

In the late 1960’s and early 1970’s there was an upsurge in the number of severe adverse reactions in children who received the 3 in 1 DPT Trivax vaccine manufactured in the UK by Wellcome.

 

Because of this upsurge Eastern Health Board records (1973) show that the official in charge of the administration of the vaccine within the Dublin Health Board region was inundated with reports of severe reactions among children.  On the 24 September 1972 the official in charge wrote to Wellcome enclosing a list of the LOT numbers of the DPT vaccine that had caused severe reactions and to express her concern. (Child Abuse (Amendment) Bill 2005 Second Stage Speech by Denis Naughten TD Vol  601 28-04-2005 No 4).

In the first 6 months of 1973 more than 80 reported adverse reactions were recorded in the inner city of Dublin.

There were so many reactions to the 3 in 1 vaccine in the early 1970’s that by 1974 only 50% of parents were opting for the 2 in 1 vaccine omitting the whooping cough/pertussis element.

 

The IMB received notice of 324 suspected adverse drug reactions to the DPT vaccine since 1972.  87 of these were classified as serious in accordance with agreed international criteria (Dail reply No 791-29 Nov 2004).

 

The EHB co-operated with Wellcome in carrying out a study in 1973 comparing 4 types of DPT vaccine.  A total of 116 children were involved – 59 from the community and 57 from two children’s homes in the Dublin area.

Vaccine Trials in the Orphanages

The vaccine trials known as ‘Vaccine Trials In the Orphanages’ were part of the Child Abuse Commission investigation set up by the Government in 2000 to examine child abuse in the State. The inquiry had been looking at three trials of vaccines involving children in orphanages and children in the community in 1960/61 1970 and 1973. On 28 November 2006 Health Minister Harney halted the vaccine inquiry module following ‘a detailed examination of judgments in court cases related to the vaccine trials in both the High and Supreme Courts’.

Expert Group

An Expert Medical Group was set up by Health Minister Michael Woods in 1977 to 1984 to assess whether individuals who presented themselves to it were brain damaged by whooping cough vaccine – the decision was on the ‘balance of probabilities’. 93 people went before the committee – 16 were offered an ex gratia payment of £10,000 – 77 applications were declined.

 

Best Case

A DPT vaccine Batch that was administered in the late 1960’s and early 1970’s was Batch No 3741 and a vaccine LOT from this Batch was administer to a child from Co Cork called Kenneth Best.  In 1992 this case came before the Supreme Court and it was successfully proven that Toxic Vaccine was used widely in Ireland and caused brain damage. Batch 3741 failed 2 laboratory tests for potency and toxicity.  It was 8 times more potent than the recommended strength.

 

At the conclusion of the Best Case Justice Liam Hamilton described Wellcome as negligent and criticized the company’s quality control procedures.

 

Following the Supreme Court Judgment Kenneth Best received £2.75M by the vaccine manufacturers Wellcome for the permanent brain damage he suffered when vaccinated with vaccine from Batch 3741.

 

The ‘Best Case’ was the only successful vaccine damage litigation case in Ireland to-date.

 

Wellcome withdrew the wholecell pertussis vaccine in Ireland in 1993.

 

The Government under Health Minister Michael Noonan introduced acellular pertussis vaccine in 1993 because of the adverse effects of the wholecell pertussis vaccine.

TOXIC BATCH 3741

A search for Batch 3741 was ordered by the then Health Minister Brian Cowen after Glaxo Wellcome the drug company now called Glaxo Smith Klyne (GSK) made available the LOT numbers taken from the “Toxic Batch” at the centre of the Best Case.

Health Minister Michael Martin issued a report on the use of 3 in 1 vaccine

Report:

The Minister for Health and Children, Micheál Martin, T.D., today (27 February 2001) issued a report on the usage in Ireland of Trivax three-in-one vaccine from the batch which was at issue in the case of Kenneth Best. In 1992 the Supreme Court found that the Wellcome Foundation was liable for the disability of Kenneth Best, who had been immunised with this product in 1969. The particular vaccine batch involved was number 3741, which had been produced in 1968 and is believed to have had a shelf-life of two years.

The Minister said that in the light of the Best judgement, he and his Department had been approached from time to time on behalf of a number of individuals, whose families believe that they may have suffered damage as a result of receiving three-in-one vaccine, seeking assistance in tracing the batch or lot numbers administered in these cases.

The Department has been in contact with the manufacturer of this product, and also asked the health boards to examine their records to establish what information is available. “Much of the information obtained about the usage in Ireland of vaccine from batch 3741 has already been placed in the public domain. The purpose of this document is to set out clearly and comprehensively the information obtained by my Department about the issues involved”, the Minister said.

The report issued by the Minister indicates that 296 individuals are recorded as having received vaccine from lots produced from batch 3741 in the period 1968-1971. The number of recipients in each of the health boards concerned (the Mid-Western, North-Western, Southern and Western Health Boards) is as follows:

  No. of persons Period of usage
Mid-Western Health Board 183 October 1969 – October 1970
North-Western Health Board 3 November 1969 – February 1970
Southern Health Board 107 June 1969 – October 1971
Western Health Board 3 September 1969

Full details are contained in the report. The other health boards did not succeed in tracing any records containing the lot numbers concerned. The report issued by the Minister is available on the Department of Health and Children’s website “www.doh.ie”.

The health boards had undertaken detailed searches of their records for a period which predated the establishment of the health boards. In many cases immunisation records for this period no longer exist, or where they exist do not contain vaccine lot numbers involved. It would appear reasonable, however, to assume that vaccine from the batch concerned was administered more widely than in the 296 cases documented in the records which have been traced.

The records obtained suggest that in some instances vaccine may have been administered after its expiry date. However it is difficult at this stage to be certain about this, as full information on the expiry date of all vaccine lots is not available.

The Minister said that he has written to the Chief Executive Officers of the four health boards concerned, asking them to endeavour to trace the individuals who received this product and to inform them accordingly.

The Minister added that the expert medical consensus is that wholecell pertussis vaccine has not been proven to be a cause of brain damage. He said that this view has been confirmed by the Immunisation Advisory Committee of the Royal College of Physicians of Ireland, which has stated that “although there has been controversy about pertussis vaccine the consensus from authoritative bodies is that it is a safe vaccine” (Immunisation Guidelines for Ireland, RCPI, 1996, p.25).

Joint Oireachtas Committee on Health and Children

As part of it work programme for 2000 and 2001 the Joint Committee examined the issue of ‘Childhood Immunisation’ to include an examination of current vaccination policy and practices – poor take-up rates and public concerns about the risks and adverse effects of vaccination. In excess of 100 submissions were received from the public and the medical profession and other interested parties. In its Report of July 2001 this committee recommended that a vaccine damage compensation scheme be set up at the earliest possible date.

Vaccine Damage Steering Group

Following on from the Report of the Joint Oireachtas Committee on Health & Children on ‘Childhood Immunisation’ the Minister for Health & Children Mary Harney established a ‘Vaccine Damaged Steering Group’ early in 2007. Chaired by Chris Fitzgerald Principal Officer Public Health Division the group’s brief was to examine the issue of vaccine damage including compensation options. Submissions were invited from members of the public or interested groups on the issue of vaccine damage – 124 submissions were received from members of the public and 7 from interested groups up to 15 November 2009.

The Report of the Vaccine Damage Steering Group was released on 17 November 2009

The Group recommended that a ‘no fault’ ex-gratia compensation payment scheme be established and administered by the Department of Social and Family Affairs. A scheme consisting of a three tiered structure depending on the severity of damage is recommended and this applies to all cases of vaccination whensoever they occurred – provided they meet the eligibility criteria.

The Minister for Health and Children Mary Harney and her Department are currently considering the recommendations of the Vaccine Damage Steering Group Report in detail.

www.dohc.ie/publications/


http://www.theguardian.com/uk/2002/jun/30/tracymcveigh.antonybarnett

UK babies given toxic vaccines, admits Glaxo


British drug giant GlaxoSmithKline has finally admitted that thousands of babies in this country were inoculated with a batch of toxic whooping cough vaccines in the 1970s.

Some experts believe that these Trivax vaccines – which had not passed critical company safety tests – may have caused permanent brain damage and even fatalities in young children.

In 1992, the family of an Irish boy, Kenneth Best, who suffered brain damage from one of these toxic vaccines, was awarded £2.7 million in compensation by the Irish Supreme Court.

Despite a long and fierce battle with the drug giant, the boy’s family finally won this historic case after his mother Margaret made a startling find when sifting through tens of thousands of company documents.

She discovered that the Trivax vaccine used on her son, from a batch numbered 3,741, had been released by the company despite it having failed to pass a critical safety test. Documents revealed that the 60,000 individual doses within this batch were known to be 14 times more potent than normal.

At the time the Irish judge accused GlaxoSmithKline – then known as Glaxo Wellcome – of negligence and attacked the company’s poor quality control at its Kent laboratory. Immunology experts condemned Glaxo in court for what one US scientist described as an ‘extraordinary event’.

Last year an investigation by The Observer found evidence to suggest that vaccines from this faulty batch, which may have wrecked Kenneth Best’s life, had also been used in Britain.

Liberal Democrat MP Norman Baker raised questions in the House of Commons, asking whether vaccines from this batch had been given to British babies. Then Health Minister Yvette Cooper wrote to the company asking for information.

Now, almost a year later, GlaxoSmithKline has replied that it is ‘highly probable’ the toxic batches had been used in Britain.

The Department of Health is under pressure to make efforts to trace the children who received the suspect vaccines.

Last week in the House of Commons, Health Minister Hazel Blears said: ‘Unfortunately they no longer have details of the quantitites of vaccine or the places where the vaccine was supplied.

‘Since vaccines were not centrally purchased and distributed at that time there are no central records either. Information on individuals who received these vaccines will only exist if the general practioner at the time of the immunisation recorded the batch number and the patient’s notes are still available.’

Baker will now write to the Minister to demand that she asks health authorities to check the records to find out who received the vaccine. It is believed that at least one boy from Wales died after receiving a jab from toxic batch 3,741, although the parents have never been informed.

A spokesman for GlaxoSmithKline told The Observer : ‘We do not accept that these batches were harmful.’

Access Campaign: MSF delivers petition of nearly 400,00 people who demand Pfizer and GSK cut the price of pneumonia vaccine


http://www.msf.org/en/article/access-campaign-msf-delivers-petition-nearly-40000-people-who-demand-pfizer-and-gsk-cut

Access Campaign: MSF delivers petition of nearly 400,00 people who demand Pfizer and GSK cut the price of pneumonia vaccine

2,500 flowers are placed in front of Pfizer’s HQ, representing number of children who die of pneumonia each day.

New York – Despite there being a vaccine that can prevent it, pneumonia remains the leading global cause of childhood death in many developing countries, killing almost one million kids per year.

On the eve of Pfizer’s annual shareholder meeting, Médecins Sans Frontières (MSF) delivered to Pfizer headquarters the names of nearly 400,000 people who signed a petition demanding that pharmaceutical companies Pfizer and GlaxoSmithKline (GSK) reduce the price of the pneumonia vaccine to US$5 per child in all developing countries and for humanitarian organisations.

“Millions of babies and young kids around the world are left unprotected against pneumonia because Pfizer and GSK charge such high prices for the pneumonia vaccine that many governments and humanitarian organisations can’t afford to vaccinate children,” said Dr. Greg Elder, Medical Coordinator at MSF’s Access Campaign. “After combined sales of more than $30 billion for the pneumonia vaccine alone, we think it’s pretty safe to say that Pfizer and GSK can afford to lower the price so all developing countries can protect their children from this childhood killer.”

MSF delivered the petition during a stunt outside Pfizer’s global headquarters in New York, where dozens of people  placed flowers at the company’s door. One flower was laid for every child lost to pneumonia each day, resulting in 2,500 flowers – representing the number of kids who would die from pneumonia that day – piled in front of Pfizer’s front door. Reams of paper with the names of nearly 400,000 people from 170 countries who signed MSF’s ‘A FAIR SHOT’ petition lay in an empty baby crib. The petition urges the two companies making the pneumonia vaccine to drop the price to $5 per child (for all three doses). With Pfizer having earned more than $6 billion in sales for this vaccine just last year alone, signatories of the petition sent a strong signal to Pfizer’s CEO, board and shareholders that the company should not put billions of dollars in profits over children’s lives.

Last year, 193 governments at the World Health Assembly unanimously passed a landmark resolution demanding more affordable vaccines and increased transparency around vaccine prices. The governments of more than 50 countries underlined the rising inequities among them caused by the increased financial burden of new vaccines, with many stating that the high price of new vaccines, such as the pneumonia vaccine, either prohibited them from introducing it or threatened their ability to maintain it in their routine immunisation programmes. Countries such as Algeria, Bosnia, Egypt, Indonesia, Jordan, Thailand, and Tunisia, among others, have expressed that they are not able to introduce the pneumonia vaccine because of its high price.

MSF has vaccinated children caught in emergencies with the pneumonia vaccine in the Central African Republic, Ethiopia, South Sudan, Uganda and other countries. After more than five years of struggling to get Pfizer and GSK to sell the vaccine to MSF at an affordable price, MSF last year launched its ‘A FAIR SHOT’ campaign to push the companies to reduce the price of the pneumonia vaccine to $5 per child (for all three doses).

In 2015, MSF released its vaccine pricing report, The Right Shot: Bringing Down Barriers to Affordable and Adapted Vaccines, which showed that in the poorest countries it is now 68 times more expensive to vaccinate a child than in 2001, with many parts of the world unable to afford new high-priced vaccines like that against pneumonia.

“We’ve seen too many children die of pneumonia, and we’re not going to stop until we know that all countries can afford this life-saving vaccine,” said Elder. “It’s tremendous to see that nearly 400,000 people globally have joined us to tell Pfizer and GSK they must drop the price so more kids’ lives can be saved. What’s the point of a life-saving vaccine if the most vulnerable people can’t afford it?”

Are GSK’s Global Manufaturing Violations A Ticking Time Bomb?


“..The US watchdog said when it inspected the site in Sainte-Foy, Quebec, in April it found that the plant had failed to take appropriate steps to prevent microbiological contamination of drug products purporting to be sterile.

It also found that controls for the purified water system at the site, which employs 600 people, were inadequate to prevent contamination..”

(The Guardian 2014).

 

Another interesting comment (below) left on my blog today by an “Ex GSK‘ employee/whistleblower…

https://truthman30.wordpress.com/2016/02/27/great-thesis-on-gsks-corruption-in-china/

 


 

“…Ms. Kollewe was onto something in the link below. I’ve been awaiting her follow up for months now but the trail must have gone cold.

Witty, Lord and fCoB have been fully informed regarding major contributing factors but it’s been buried, for now.

A systemic ticking time bomb within their global manufacturing operations…

http://www.theguardian.com/business/2014/jun/24/glaxo-fda-flu-vaccines-review-manufacturing


In the article that the whistleblower is referring to..

He seems to be drawing attention to alleged violations in manufacturing quality of GSK’s Flulaval drug…

Is Flulaval another dodgy drug from GSK?

Are GSK involved in another cover up?

Are GSK’s Global Manufacturing Violations A Ticking Time Bomb?

Quite possibly..

From the Guardian (2014)

http://www.theguardian.com/business/2014/jun/24/glaxo-fda-flu-vaccines-review-manufacturing


FDA orders GlaxoSmithKline to review manufacturing worldwide

Britain’s biggest drugmaker warned by US watchdog over flu vaccine production at Canadian subsidiary
GlaxoSmithKline headquarters
GlaxoSmithKline sold 26m doses of flu vaccines in the US last year, generating £150m in sales. Photograph: Photofusion/Rex Features

The US Food and Drug Administration has ordered GlaxoSmithKline to review its manufacturing operations globally after finding that its Canadian subsidiary violated quality requirements during the manufacture of its flu vaccine FluLaval.

It is another serious blow to Britain’s biggest drugmaker, already reeling from corruption allegations in Poland, Iraq, Jordan, Lebanon and China, and facing a criminal investigation by the UK’s Serious Fraud Office into its sales practices. It also recently paid out £63m to settle US marketing allegations. Earlier this week GSK had to apologise for the pitch adopted by a marketing firm working for the FTSE 100 company to recruit unpaid interns for clinical trials in the UK.

In a warning letter to the British company, the FDA cited “deviations from current good manufacturing practice” in the manufacture of FluLaval at GSK’s Quebec-based subsidiary ID Biomedical, which makes the vaccine for Canada and the US.

The US watchdog said when it inspected the site in Sainte-Foy, Quebec, in April it found that the plant had failed to take appropriate steps to prevent microbiological contamination of drug products purporting to be sterile. It also found that controls for the purified water system at the site, which employs 600 people, were inadequate to prevent contamination.

The FDA said it “expects ID Biomedical and GSK to undertake a comprehensive and global assessment of all of its manufacturing operations to ensure that all products conform to FDA requirements”.

The letter piles further pressure on GSK’s boss, Sir Andrew Witty, who pledged a major overhaul of the company two years ago after a £1.9bn US fine for mis-selling drugs. At the same time, he has been behind industry leading measures on data transparency, clinical trials and access to medicines. The company also claims that Witty has transformed sales and manufacturing practices. GSK said on Tuesday that it was working with the FDA and making progress addressing the concerns. “We are committed to working with the agency to fully resolve all outstanding issues,” the drugmaker added.

“Patient safety is our first priority and we are confident in the safety of the influenza vaccines we have provided to patients. Every batch of GSK vaccines is subject to extensive review before it is released. Vaccines that do not pass this rigorous review are discarded.”

Pending FDA approvals, GSK now expects to provide between 28m and 33m doses of flu vaccine to the US health authorities for next winter. It had planned to supply 36m doses, 23m of which would be made in the Sainte-Foy site in Quebec. GSK is also working with the Canadian health authorities to meet its supply commitments for 2014-15.

GSK sold 26m doses of flu vaccines (Fluarix and FluLaval) in the US last year, which generated £150m in sales. While it is still working to determine the impact the FDA concerns will have on supply, it expects to increase output this year. Its sites in Dresden in Germany and Rixensart in Belgium, which make Fluarix, are not affected by the warning letter.

Vaccines is one of GSK’s key growth areas. The company won plaudits within the industry when it unveiled a complex asset swap with Switzerland’s Novartis in April. GSK beefed up its vaccines business with the acquisition of Novartis’s vaccines divisions for up to $7.1bn and offloaded its portfolio of cancer drugs.

GSK points out that it had six new medicines approved by the FDA last year, nearly a fifth of all approvals and the highest number of any drugmaker.

In early June, GSK settled allegations by 44 US states and the District of Columbia going back 14 years that it promoted its big-selling medicines Advair, Paxil and Wellbutrin for unapproved uses. The £1.9bn Federal fine from the FDA for mis-selling drugs also related to anti-depressents Paxil and Wellbutrin as well as Avandia, once the world’s most popular type-2 diabetes drug, until it was found to have potential serious side effects, including heart attacks.

Access: MSF launches global action against Pfizer and GlaxoSmithKline to cut the price of the pneumonia vaccine


http://www.msf.org/article/access-msf-launches-global-action-against-pfizer-and-glaxosmithkline-cut-price-pneumonia

Access: MSF launches global action against Pfizer and GlaxoSmithKline to cut the price of the pneumonia vaccine

Share
MSF dumps US$17 million in fake cash at Pfizer’s New York HQ, the amount the company makes in one day of pneumonia vaccine sales

New York – Médecins Sans Frontières (MSF) launched a global petition today, World Pneumonia Day, calling on pharmaceutical companies Pfizer and GlaxoSmithKline (GSK) to reduce the price of the pneumonia vaccine to US$5 per child (for all three doses) in all developing countries and for humanitarian organisations.

After years of fruitless negotiations with both companies to lower the vaccine’s price for use in its projects in developing countries and in humanitarian crises, MSF called on the public to help put pressure on the companies. Pneumonia is the leading global cause of childhood death and kills nearly one million children each year.

SIGN THE PETITION AT AFAIRSHOT.ORG

“The pneumonia vaccine is the world’s best-selling vaccine, and last year, Pfizer brought in more than US$4.4 billion in sales just from this product,” said Dr Manica Balasegaram, Executive Director of MSF’s Access Campaign. “Pfizer and GSK charge such high prices for the pneumonia vaccine that many governments and humanitarian organisations aren’t able to vaccinate children. After combined sales to date of more than US$28 billion for the pneumonia vaccine alone, we think it’s pretty safe to say that Pfizer and GSK can afford to lower the price so all developing countries can protect their children from this childhood killer.”

With Pfizer earning more than US$17 million in sales per day from the pneumonia vaccine alone, MSF kicked off the petition campaign on World Pneumonia Day with a stunt outside the company’s headquarters in New York, attempting to deliver more than US$17 million of fake cash to Pfizer’s CEO Ian Read. MSF also placed an advertisement in the bus stop shelter directly in front of the Pfizer building, which posed the question: “Hey Pfizer, why are your vaccines priced out of reach of children in need?”

In January, MSF released its vaccine pricing report, The Right Shot: Bringing Down Barriers to Affordable and Adapted Vaccines, which showed that in the poorest countries, with the addition of new vaccines, it is now 68 times more expensive to vaccinate a child than in 2001, with many parts of the world unable to afford new high-priced vaccines like that against pneumonia.

“As doctors who have watched far too many children die from pneumonia, we’re not going to back down until we know that all countries can afford the vaccine,” said Dr Balasegaram. “We’re asking you to join our global effort by signing the petition to tell Pfizer and GSK it’s time to drop the price of the pneumonia vaccine.”

In May, 193 governments met in Geneva for the annual World Health Assembly, where they unanimously passed a landmark resolution demanding more affordable vaccines and increased transparency around vaccine prices. The governments of over 50 countries underlined the rising inequities among them caused by the increased financial burden of new vaccines, with many stating the high price of new vaccines, such as the pneumonia vaccine, either prohibited them from introducing it or threatened their ability to sustain it in their routine immunization programmes.

“What’s the point of a life-saving vaccine if the most vulnerable people can’t afford it?” asked Dr Balasegaram.

SIGN THE PETITION AFAIRSHOT.ORG


Each year, MSF teams vaccinate millions of people, both as outbreak response to diseases such as measles, meningitis, yellow fever and cholera, as well as routine immunisation activities in projects where it provides health care to mothers and children. In 2014 alone, MSF delivered more than 3.9 million doses of vaccines and immunological products. MSF has purchased the pneumococcal conjugate vaccine in the past for use in its emergency operations. MSF is scaling up its use of the pneumococcal conjugate vaccine and other vaccines with a particular focus on improving its work in routine immunisation, as well as extending the package of vaccines used in humanitarian emergencies. MSF has vaccinated children caught in emergencies with PCV in Central African Republic, Ethiopia, South Sudan, and Uganda.

%d bloggers like this: